Fulvestrant is used for treating patients who have HR +Ve metastatic breast cancer in the postmenopausal women with disease progression and HR +Ve, HER2 -Ve advanced breast cancer and palbociclib in women with disease progression after the therapy of endocrine. Fulvestrant is an estrogen receptor antagonist that binds to the estrogen receptor competitively with an affinity comparable to that of estradiol and downregulates the ER protein in human breast cancer cells. Fulvestrant is a white powder, and this solution for injection is a clear, colorless to yellow, viscous liquid. Fulvestrant injection is readily available from several generic medicine suppliers. To know more about this medicine, contact us on toll-free no. 18008891064.
Nice Airport Taxi
Ok365
Hurricane Us Com
F8bet
32win
Kp88
Rr88
Samuel Canales
Johansen Herman
789club